Glen Eagle Advisors’s Alkermes ALKS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-20
Closed -$560 1019
2025
Q4
$560 Hold
20
﹤0.01% 994
2025
Q3
$600 Hold
20
﹤0.01% 1041
2025
Q2
$572 Hold
20
﹤0.01% 976
2025
Q1
$660 Hold
20
﹤0.01% 972
2024
Q4
$575 Hold
20
﹤0.01% 1018
2024
Q3
$560 Hold
20
﹤0.01% 1063
2024
Q2
$482 Buy
+20
New +$491 ﹤0.01% 1067

Other funds holding ALKS

Glen Eagle Advisors's ALKS Position: Q1 2026 in Review

Glen Eagle Advisors sold out of Alkermes (ALKS) in Q1 2026, closing a stake of 20 shares — an estimated $560 sold.

Glen Eagle Advisors first reported a position in ALKS in Q2 2024 and held it in 7 quarters. The position peaked at $660 in Q1 2025. 390 funds tracked by Wall St. Rank hold ALKS as of Q1 2026.

  • Glen Eagle Advisors reported no remaining Alkermes position as of Q1 2026 after selling out during the quarter.
  • Glen Eagle Advisors sold 20 Alkermes shares in Q1 2026, an estimated $560.
  • Glen Eagle Advisors first reported a position in Alkermes in Q2 2024 and held it in 7 quarters.
  • Glen Eagle Advisors's Alkermes position peaked at $660 in Q1 2025.
  • 390 funds tracked by Wall St. Rank held Alkermes as of Q1 2026.

Based on Glen Eagle Advisors's 13F filing for Q1 2026, filed 15 May 2026.